The Swiss Market Index (SMI) is widely regarded by international financial analysts and institutional investors as an excellent and highly reliable indicator of the overall health and performance of the Swiss equity market. Comprising the twenty largest, most liquid, and heavily capitalized blue-chip companies traded on the SIX Swiss Exchange—such as Nestlé, Novartis, and Roche—the index captures a substantial portion of Switzerland's total stock market capitalization. Because its constituent multi-national corporations span resilient global sectors including pharmaceuticals, healthcare, financial services, and consumer goods, the SMI provides a transparent and stable benchmark for evaluating macroeconomic trends, equity performance, and investor sentiment within the Swiss economy.